In the central nervous system (CNS), dopamine is involved in the contr
ol of locomotion, cognition, affect and neuroendocrine secretion. Thes
e actions of dopamine are mediated by five different receptor subtypes
, which are members of the large G-protein coupled receptor superfamil
y. The dopamine receptor subtypes are divided into two major subclasse
s: the D-1-like and D-2-like receptors, which typically couple to G(s)
and G(j) mediated transduction systems. In the CNS, the various recep
tor subtypes display specific anatomical distributions, with D-1-like
receptors being mainly post-synaptic and D-2-like receptors being both
pre- and post-synaptic. D-1 and D-2 dopamine receptors, the most abun
dant subtypes in the CNS, appear to be expressed largely in distinct n
eurons. Substance P and dynorphin, which are expressed in D-1 receptor
-containing neurons, as well as pre-proenkephalin in D-2 receptor-cont
aining neurons, have been used as monitors of dopaminergic activity in
the CNS. Expression of immediate early genes, in particular fos, has
also been found to correlate with dopaminergic transmission. Dopamine
released from the hypothalamus controls the synthesis and secretion of
prolactin from the anterior pituitary via D-2 dopamine receptors. As
yet, none of the dopamine receptor subtypes have been associated with
the etiology of psychotic disorders, such as schizophrenia. However, t
he recent characterization of D-3 and D-4 receptors which are, interes
tingly, expressed in areas of the CNS mediating cognition and affect o
r showing increased affinity for certain neuroleptics, have renewed th
e interest and hope of finding effective neuroleptics devoid of side e
ffects. Finally, the recent production of genetically-derived animals
lacking several of these receptor genes should help elucidate which sp
ecific physiological paradigms the receptors mediate. Copyright (C) 19
96 Elsevier Science Ltd.